<DOC>
	<DOCNO>NCT01212965</DOCNO>
	<brief_summary>The investigator propose pilot trial obtain preliminary information regard safety response rate patient symptomatic lymphatic malformation treat oral Selenium . Information obtain pilot trial use plan future phase 2 clinical trial . Hypotheses : - Selenium safe efficacious treatment adolescent young adult symptomatic lymphatic malformation - Disease response correlate serum level selenium blood level antioxidants essential selenium metabolism .</brief_summary>
	<brief_title>Selenium Treatment Complicated Lymphatic Malformations</brief_title>
	<detailed_description />
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Lymphangioma</mesh_term>
	<mesh_term>Lymphatic Abnormalities</mesh_term>
	<mesh_term>Selenium</mesh_term>
	<criteria>Patients must clinical radiographic feature consistent lymphatic malformation ( LM ) . Patients combine venous lymphatic malformation ( CVLM ) include predominant componet lymphatic base MRI . Both macrocystic microcystic LM eligible . Tissue biopsy require confirm presence abnormal lymphatic malformation . All patient diagnose lymphatic malformation 14 30 year age eligible . Patients must lymphatic malformation potential cause morbidity include one following : Lymphedema , Coagulopathy , Chronic Pain , Recurrent Cellulitis ( &gt; 1 episodes/year ) , Ulceration and/or bleeding , Impairment organ function , Visceral and/or bone involvement , Disfigurement . Patients receive previous systemic therapy , surgical , debulking , sclerotherapy eligible eight week follow completion therapy meet inclusion criterion . All patient and/or parent legal guardian must sign write informed consent . All institutional FDA requirement human study must meet . Younger 14 year age old 30 year age Lifethreatening complication related LM Patients preexist renal , hepatic , thyroid disorder Patients receive daily multivitamin supplement natural product include selenium Patients receive previous selenium therapy eligible Women pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Selenium</keyword>
	<keyword>Lymphatic Malformations</keyword>
	<keyword>Adolescents</keyword>
</DOC>